Working… Menu
Trial record 1 of 1 for:    NCT04580420
Previous Study | Return to List | Next Study

Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD (PHYOX7)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04580420
Recruitment Status : Recruiting
First Posted : October 8, 2020
Last Update Posted : July 8, 2021
Information provided by (Responsible Party):
Dicerna Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2022
Estimated Study Completion Date : May 2025